65 related articles for article (PubMed ID: 7585447)
1. Inhibitory effects of vesicles shed by human breast carcinoma cells on lymphocyte 3H-thymidine incorporation, are neutralised by anti TGF-beta antibodies.
Dolo V; Pizzurro P; Ginestra A; Vittorelli ML
J Submicrosc Cytol Pathol; 1995 Oct; 27(4):535-41. PubMed ID: 7585447
[TBL] [Abstract][Full Text] [Related]
2. Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells.
Dolo V; Ginestra A; Cassarà D; Violini S; Lucania G; Torrisi MR; Nagase H; Canevari S; Pavan A; Vittorelli ML
Cancer Res; 1998 Oct; 58(19):4468-74. PubMed ID: 9766680
[TBL] [Abstract][Full Text] [Related]
3. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
[TBL] [Abstract][Full Text] [Related]
4. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
5. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Franzén P; Ichijo H; Miyazono K
Exp Cell Res; 1993 Jul; 207(1):1-7. PubMed ID: 7686495
[TBL] [Abstract][Full Text] [Related]
6. Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities.
Dolo V; Ginestra A; Ghersi G; Nagase H; Vittorelli ML
J Submicrosc Cytol Pathol; 1994 Apr; 26(2):173-80. PubMed ID: 8019942
[TBL] [Abstract][Full Text] [Related]
7. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
Herman ME; Katzenellenbogen BS
Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
[TBL] [Abstract][Full Text] [Related]
8. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
9. Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family.
Vrana JA; Stang MT; Grande JP; Getz MJ
Cancer Res; 1996 Nov; 56(21):5063-70. PubMed ID: 8895765
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta is not the major soluble immunosuppressor in the microenvironments of human breast tumours.
Xie J; Gallagher G
Anticancer Res; 1992; 12(6B):2117-21. PubMed ID: 1295457
[TBL] [Abstract][Full Text] [Related]
12. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta, osteogenin, and bone morphogenetic protein-2 inhibit intercellular communication and alter cell proliferation in MC3T3-E1 cells.
Rudkin GH; Yamaguchi DT; Ishida K; Peterson WJ; Bahadosingh F; Thye D; Miller TA
J Cell Physiol; 1996 Aug; 168(2):433-41. PubMed ID: 8707879
[TBL] [Abstract][Full Text] [Related]
15. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia.
Rønnov-Jessen L; Petersen OW
Lab Invest; 1993 Jun; 68(6):696-707. PubMed ID: 8515656
[TBL] [Abstract][Full Text] [Related]
16. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
[TBL] [Abstract][Full Text] [Related]
17. The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness.
Ginestra A; La Placa MD; Saladino F; Cassarà D; Nagase H; Vittorelli ML
Anticancer Res; 1998; 18(5A):3433-7. PubMed ID: 9858920
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
19. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
[TBL] [Abstract][Full Text] [Related]
20. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
